Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05031468 · ClinicalTrials.gov registry record
Multisite Observational Maternal and Infant Study for COVID-19
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 562
- Enrollment target
NCT05031468 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 562 participants.
The verdict
NCT05031468 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 562 participants
- Enrollment target
Study Summary
This is an observational, non-interventional, prospective cohort study designed to collect clinical information and specimens to evaluate the immune responses from pregnant individuals and postpartum individuals and their infants following maternal receipt of licensed or Emergency Use Authorization (EUA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.
Interventions
- BIOLOGICAL Licensed or EUA SARS-CoV-2 vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 562 participants |
| Start Date | 2021-07-06 |
| Est. Completion | 2023-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05031468
The ClinicalTrials.gov registry entry for NCT05031468 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 562 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Licensed or EUA SARS-CoV-2 vaccine is the first listed.
NCT05031468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05031468 about?
NCT05031468 is a clinical study titled "Multisite Observational Maternal and Infant Study for COVID-19". This is an observational, non-interventional, prospective cohort study designed to collect clinical information and specimens to evaluate the immune responses from pregnant individuals and postpartum individuals and their infants following maternal receipt of licensed or Emergency Use Authorization ...
What is the current status of trial NCT05031468?
This trial is currently completed. The enrollment target is 562 participants. The study started on 2021-07-06. Estimated completion is 2023-08-16.
What interventions are being tested in trial NCT05031468?
The interventions under investigation include: Licensed or EUA SARS-CoV-2 vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT05031468?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.